Differentiation of Lung Cancer, Empyema, and Abscess Through the Investigation of a Dry Cough
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Etiology of Pulmonary Abscess
University of Nebraska Medical Center DigitalCommons@UNMC MD Theses Special Collections 5-1-1933 Etiology of pulmonary abscess Lucien Sears University of Nebraska Medical Center This manuscript is historical in nature and may not reflect current medical research and practice. Search PubMed for current research. Follow this and additional works at: https://digitalcommons.unmc.edu/mdtheses Recommended Citation Sears, Lucien, "Etiology of pulmonary abscess" (1933). MD Theses. 291. https://digitalcommons.unmc.edu/mdtheses/291 This Thesis is brought to you for free and open access by the Special Collections at DigitalCommons@UNMC. It has been accepted for inclusion in MD Theses by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. THE ETIOLOG~ OF PUL~ONARY ABSCESS By Lucien Sears University of Nebraska Medical College • Senior Thesis 1933 "?REFACE The purpose of this paper is to pre- sent so far as possible a modern and ra- tional explanation of the etiology of pul- monary abscess. No attempt has been made, in writing this paper, to include the symptomatology, pathology, diagnosis or therapy of pulmon ary abscess. The references were chosen with the idea that they are useful references, that is to say references which I have found use- ful, although for the most part quite recent, they will be found to contain a number of older articles. INTRODUCTION. The term lung abscess has come to be rather loose ly applied to a variety of conditions. Strictly speak ing it consists of a focus of suppuration within the parenchyma of the lung; but in current literature has come to include suppuration within the bronchial tree and even between apposing pleural surfaces. -
Mediastinitis and Bilateral Pleural Empyema Caused by an Odontogenic Infection
Radiol Oncol 2007; 41(2): 57-62. doi:10.2478/v10019-007-0010-0 case report Mediastinitis and bilateral pleural empyema caused by an odontogenic infection Mirna Juretic1, Margita Belusic-Gobic1, Melita Kukuljan3, Robert Cerovic1, Vesna Golubovic2, David Gobic4 1Clinic for Oral and Maxillofacial Surgery, 2Clinic for Anaesthesiology and Reanimatology, 3Department of Radiology, 4Clinic for Internal Medicine, Clinical hospital, Rijeka, Croatia Background. Although odontogenic infections are relatively frequent in the general population, intrathoracic dissemination is a rare complication. Acute purulent mediastinitis, known as descending necrotizing mediastin- itis (DNM), causes high mortality rate, even up to 40%, despite high efficacy of antibiotic therapy and surgical interventions. In rare cases, unilateral or bilateral pleural empyema develops as a complication of DNM. Case report. This case report presents the treatment of a young, previously healthy patient with medias- tinitis and bilateral pleural empyema caused by an odontogenic infection. After a neck and pharynx re-inci- sion, and as CT confirmed propagation of the abscess to the thorax, thoracotomy was performed followed by CT-controlled thoracic drainage with continued antibiotic therapy. The patient was cured, although the recognition of these complications was relatively delayed. Conclusions. Early diagnosis of DNM can save the patient, so if this severe complication is suspected, thoracic CT should be performed. Key words: mediastinitis; empyema, pleural; periapical abscess – complications Introduction rare complication of acute mediastinitis.1-6 Clinical manifestations of mediastinitis are Acute suppurative mediastinitis is a life- frequently nonspecific. If the diagnosis of threatening infection infrequently occur- mediastinitis is suspected, thoracic CT is ring as a result of the propagation of required regardless of negative chest X-ray. -
Redalyc.COMUNICAÇÕES ORAIS
Revista Portuguesa de Pneumología ISSN: 0873-2159 [email protected] Sociedade Portuguesa de Pneumologia Portugal COMUNICAÇÕES ORAIS Revista Portuguesa de Pneumología, vol. 23, núm. 3, noviembre, 2017 Sociedade Portuguesa de Pneumologia Lisboa, Portugal Disponível em: http://www.redalyc.org/articulo.oa?id=169753668001 Como citar este artigo Número completo Sistema de Informação Científica Mais artigos Rede de Revistas Científicas da América Latina, Caribe , Espanha e Portugal Home da revista no Redalyc Projeto acadêmico sem fins lucrativos desenvolvido no âmbito da iniciativa Acesso Aberto Document downloaded from http://www.elsevier.es, day 06/12/2017. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited. COMUNICAÇÕES ORAIS CO 001 CO 002 COPD EXACERBATIONS IN AN INTERNAL MEDICINE MORTALITY AFTER ACUTE EXACERBATION OF COPD WARD REQUIRING NONINVASIVE VENTILATION C Sousa, L Correia, A Barros, L Brazão, P Mendes, V Teixeira D Maia, D Silva, P Cravo, A Mineiro, J Cardoso Hospital Central do Funchal Serviço de Pneumologia do Hospital de Santa Marta, Centro Hospitalar de Lisboa Central Key-words: COPD, Hospital admissions, Follow-up, Management, Indicators Key-words: AECOPD, NIV, Mortality Introduction: Chronic obstructive pulmonary disease (COPD) Introduction: Acute COPD exacerbations (AECOPD) are serious is a major cause of morbidity and mortality. The occurrence of episodes in the natural history of the disease and are associ - acute exacerbations (AE) contributes to the gravity of the dis - ated with significant mortality. Noninvasive ventilation (NIV) is a ease. Many of these cases are admitted in an Internal Medicine well-established therapy in hypercapnic AECOPD. -
Organizing Pneumonia As a Histopathological Term
Turk Thorac J 2017; 18: 82-7 DOI: 10.5152/TurkThoracJ.2017.16047 ORIGINAL ARTICLE Organizing Pneumonia as a Histopathological Term Fatma Tokgöz Akyıl1, Meltem Ağca1, Aysun Mısırlıoğlu2, Ayşe Alp Arsev3, Mustafa Akyıl2, Tülin Sevim1 1Clinif of Chest Diseases, Süreyyapaşa Chest Diseases and Chest Surgery Training and Research Hospital, İstanbul, Turkey 2Clinif of Chest Surgery, Süreyyapaşa Chest Diseases and Chest Surgery Training and Research Hospital, İstanbul, Turkey 3Clinif of Pathology, Süreyyapaşa Chest Diseases and Chest Surgery Training and Research Hospital, İstanbul, Turkey Cite this article as: Tokgöz Akyıl F, Ağca M, Mısırlıoğlu A, et al. Organizing Pneumonia as a Histopathological Term. Turk Thorac J 2017;18:82-7. Abstract OBJECTIVES: Organizing pneumonia (OP) is an interstitial lung disease characterized by granulation tissue buds in alveoli and alveolar ductus, possibly accompanied by bronchiolar involvement. Histopathologically, OP may signify a primary disease and be observed as a contiguous disease or as a minor component of other diseases. In this study, the clinical significance of histopathological OP lesions and clinical and radiological features of patients with primary OP were examined. MATERIAL AND METHODS: Between January 2011 and January 2015, of 6,346 lung pathology reports, 138 patients with OP lesions were retrospectively evaluated. According to the final diagnoses, patients were grouped as reactive OP (those with final diagnosis other than OP) and primary OP (those with OP). Patients with primary OP were classified according to etiology as cryptogenic and secondary OP. Radiological evaluation was conducted within a categorization of “typical,” “focal,” and “infiltrative.” RESULTS: Of 138 patients, 25% were males and the mean age was 54±14 years. -
The Lung in Rheumatoid Arthritis
ARTHRITIS & RHEUMATOLOGY Vol. 70, No. 10, October 2018, pp 1544–1554 DOI 10.1002/art.40574 © 2018, American College of Rheumatology REVIEW The Lung in Rheumatoid Arthritis Focus on Interstitial Lung Disease Paolo Spagnolo,1 Joyce S. Lee,2 Nicola Sverzellati,3 Giulio Rossi,4 and Vincent Cottin5 Interstitial lung disease (ILD) is an increasingly and histopathologic features with idiopathic pulmonary recognized complication of rheumatoid arthritis (RA) fibrosis, the most common and severe of the idiopathic and is associated with significant morbidity and mortal- interstitial pneumonias, suggesting the existence of com- ity. In addition, approximately one-third of patients have mon mechanistic pathways and possibly therapeutic tar- subclinical disease with varying degrees of functional gets. There remain substantial gaps in our knowledge of impairment. Although risk factors for RA-related ILD RA-related ILD. Concerted multinational efforts by are well established (e.g., older age, male sex, ever smok- expert centers has the potential to elucidate the basic ing, and seropositivity for rheumatoid factor and anti– mechanisms underlying RA-related UIP and other sub- cyclic citrullinated peptide), little is known about optimal types of RA-related ILD and facilitate the development of disease assessment, treatment, and monitoring, particu- more efficacious and safer drugs. larly in patients with progressive disease. Patients with RA-related ILD are also at high risk of infection and drug toxicity, which, along with comorbidities, compli- Introduction cates further treatment decision-making. There are dis- Pulmonary involvement is a common extraarticular tinct histopathologic patterns of RA-related ILD with manifestation of rheumatoid arthritis (RA) and occurs, to different clinical phenotypes, natural histories, and prog- some extent, in 60–80% of patients with RA (1,2). -
IDSA/ATS Consensus Guidelines on The
SUPPLEMENT ARTICLE Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults Lionel A. Mandell,1,a Richard G. Wunderink,2,a Antonio Anzueto,3,4 John G. Bartlett,7 G. Douglas Campbell,8 Nathan C. Dean,9,10 Scott F. Dowell,11 Thomas M. File, Jr.12,13 Daniel M. Musher,5,6 Michael S. Niederman,14,15 Antonio Torres,16 and Cynthia G. Whitney11 1McMaster University Medical School, Hamilton, Ontario, Canada; 2Northwestern University Feinberg School of Medicine, Chicago, Illinois; 3University of Texas Health Science Center and 4South Texas Veterans Health Care System, San Antonio, and 5Michael E. DeBakey Veterans Affairs Medical Center and 6Baylor College of Medicine, Houston, Texas; 7Johns Hopkins University School of Medicine, Baltimore, Maryland; 8Division of Pulmonary, Critical Care, and Sleep Medicine, University of Mississippi School of Medicine, Jackson; 9Division of Pulmonary and Critical Care Medicine, LDS Hospital, and 10University of Utah, Salt Lake City, Utah; 11Centers for Disease Control and Prevention, Atlanta, Georgia; 12Northeastern Ohio Universities College of Medicine, Rootstown, and 13Summa Health System, Akron, Ohio; 14State University of New York at Stony Brook, Stony Brook, and 15Department of Medicine, Winthrop University Hospital, Mineola, New York; and 16Cap de Servei de Pneumologia i Alle`rgia Respirato`ria, Institut Clı´nic del To`rax, Hospital Clı´nic de Barcelona, Facultat de Medicina, Universitat de Barcelona, Institut d’Investigacions Biome`diques August Pi i Sunyer, CIBER CB06/06/0028, Barcelona, Spain. EXECUTIVE SUMMARY priate starting point for consultation by specialists. Substantial overlap exists among the patients whom Improving the care of adult patients with community- these guidelines address and those discussed in the re- acquired pneumonia (CAP) has been the focus of many cently published guidelines for health care–associated different organizations, and several have developed pneumonia (HCAP). -
Community Acquired Pneumonia Sonia Akter*, Shamsuzzaman and Ferdush Jahan
Akter et al. Int J Respir Pulm Med 2015, 2:1 International Journal of ISSN: 2378-3516 Respiratory and Pulmonary Medicine Review Article : Open Access Community Acquired Pneumonia Sonia Akter*, Shamsuzzaman and Ferdush Jahan Department of Microbiology, Dhaka Medical College, Bangladesh *Corresponding author: Sonia Akter, Department of Microbiology, Dhaka Medical College, Dhaka, Bangladesh, E-mail: [email protected] or residing in a long term care facility for > 14 days before the onset Abstract of symptoms [4]. Diagnosis depends on isolation of the infective Community-acquired pneumonia (CAP) is typically caused by organism from sputum and blood. Knowledge of predominant an infection but there are a number of other causes. The most microbial patterns in CAP constitutes the basis for initial decisions common type of infectious agents is bacteria such as Streptococcus about empirical antimicrobial treatment [5]. pneumonia. CAP is defined as an acute infection of the pulmonary parenchyma in a patient who has acquired the infection in the Microbial Pathogens community. CAP remains a common and potentially serious illness. It is associated with considerable morbidity, mortality and treatment Strep. pneumoniae accounted for over 80 percent of cases of cost, particularly in elderly patients. CAP causes problems like community-acquired pneumonia in the era before penicillin [6]. difficulty in breathing, fever, chest pains, and cough. Definitive Strep. pneumoniae is still the single most common defined pathogen clinical diagnosis should be based on X-ray finding and culture in nearly all studies of hospitalized adults with community-acquired of lung aspirates. The chest radiograph is considered the” gold pneumonia [7-9]. Other bacteria commonly encountered in cultures of standard” for the diagnosis of pneumonia but cannot differentiate bacterial from non bacterial pneumonia. -
BTS Guidelines for the Management of Pleural Infection in Children
i1 BTS GUIDELINES Thorax: first published as 10.1136/thx.2004.030676 on 28 January 2005. Downloaded from BTS guidelines for the management of pleural infection in children I M Balfour-Lynn, E Abrahamson, G Cohen, J Hartley, S King, D Parikh, D Spencer, A H Thomson, D Urquhart, on behalf of the Paediatric Pleural Diseases Subcommittee of the BTS Standards of Care Committee ............................................................................................................................... Thorax 2005;60(Suppl I):i1–i21. doi: 10.1136/thx.2004.030676 ‘‘It seems probable that this study covers the The manuscript was then amended in the light period of practical extinction of empyema as of their comments and the document was an important disease.’’ Lionakis B et al, reviewed by the BTS Standards of Care J Pediatr 1958. Committee following which a further drafting took place. The Quality of Practice Committee of the Royal College of Paediatrics and Child Health also reviewed this draft. After final approval 1. SEARCH METHODOLOGY from this Committee, the guidelines were sub- 1.1 Structure of the guideline mitted for blind peer review and publication. The format follows that used for the BTS guidelines on the management of pleural disease 1.3 Conflict of interest 1 in adults. At the start there is a summary table All the members of the Guideline Committee of the abstracted bullet points from each section. submitted a written record of possible conflicts of Following that is an algorithm summarising the interest to the Standards of Care Committee of management of pleural infection in children the BTS. There were none. These are available for (fig 1). -
Bronchiectasis, Lung Abscess
Bronchiectasis and Lung abscess Deepak Aggarwal Dept of Pulmonary Medicine Government Medical College and Hospital, Chandigarh • Bronchiectasis is defined as permanent and abnormal dilatation of the bronchi • It is a radiological/pathological diagnosis • Generally speaking, a bronchus is considered to be dilated if the broncho‐arterial ratio (its internal diameter divided by the diameter of its accompanying artery) exceeds 1 • Affects lower lobes preferentially – Permanent dilation of bronchi – peri‐bronchial inflammation and organization (fibrosis) – Can sometimes see mucopurulent debris in bronchioles Pathophysiology • Principally affects the medium‐sized bronchi, but often extends to the more distal bronchi and bronchioles. • The affected bronchi show transmural inflammation, mucosal edema, cratering, ulceration, and neovascularization. • The bronchial epithelium may show a polypoidal appearance due to underlying granuloma formation and mucosal prominence. • Dilated and tortuous bronchial arteries may be seen secondary to the development of extensive bronchial‐ pulmonary anastomoses. Microscopically…… • Bronchiectasis is associated with – Loss of cilia, – Cuboidal and squamous metaplasia, – Hypertrophy of bronchial glands, and lymphoid hyperplasia. – Intense infiltration of the bronchial wall with neutrophils, lymphocytes, and monocytes Clinical features • History of recurrent chest infections, • Cough: invariably present • Expectoration: Purulent, tenacious sputum production, frequently worse in the morning • “Dry bronchiectasis” -
Pleural Effusion a Medford, N Maskell
702 Postgrad Med J: first published as 10.1136/pgmj.2005.035352 on 4 November 2005. Downloaded from REVIEW Pleural effusion A Medford, N Maskell ............................................................................................................................... Postgrad Med J 2005;81:702–710. doi: 10.1136/pgmj.2005.035352 Pleural disease remains a commonly encountered clinical fluid may be helpful diagnostically and should always be recorded in the medical notes. A problem for both general physicians and chest specialists. pleural:serum packed cell volume .0.5 shows a This review focuses on the investigation of undiagnosed haemothorax with ,1% being not significant.3 pleural effusions and the management of malignant and parapneumonic effusions. New developments in this area Exudate compared with transudates Classically, exudates having a protein level are also discussed at the end of the review. It aims to be .30 g/l and transudates ,30 g/l. Light’s criteria evidence based together with some practical suggestions will enable differentiation more accurately when for practising clinicians. the pleural protein is unhelpful (box 2).4 Occasionally, Light’s criteria will label an effu- ........................................................................... sion in a patient with left ventricular failure taking diuretics an exudate in which case clinical leural effusions are a common medical judgement is required. problem and a significant source of morbid- ity. There is wide variation in management P Differential cell counts despite their significant prevalence, partly because of the relative lack of randomised Differential cell counting adds little diagnostic controlled trials in this area. This review con- information. Pleural lymphocytosis is common in siders: malignant and tuberculous effusions but can also be attributable to rheumatoid disease, N The approach to the investigation of the lymphoma, sarcoidosis, and chylothorax.5 undiagnosed pleural effusion. -
Management of Empyema: a Comprehensive Review
6 Review Article Page 1 of 6 Management of empyema: a comprehensive review Eiichi Kanai1, Noriyuki Matsutani1,2 1Department of Surgery, Azabu University, 2Department of Surgery, Teikyo University Hospital, Mizonokuchi, Kanagawa, Japan Contributions: (I) Conception and design: All authors; (II) Administrative support: All authors; (III) Provision of study materials or patients: All authors; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Noriyuki Matsutani, MD. Department of Surgery, Teikyo University Hospital, Mizonokuchi, 5-1-1 Futako Takatsu-ku Kawasaki- city, Kanagawa 213-8507, Japan. Email: [email protected]. Abstract: Empyema is a state of purulent pleural effusion in the thoracic cavity. The principle of treatment is the administration of appropriate antibiotics and thoracic drainage. If thoracic drainage is insufficient, thoracic surgeons may perform surgical intervention. It is important that our readers, thoracic surgeons, understand the pathogenesis of empyema and know how to treat it. Medline was used to search for English literature related to “empyema” and “pleural infection”. Searches were limited to the years 2010–2020 and limited to human studies. There have been numerous reports on empyema over the last decade. Regarding guidelines, the British Thoracic Society issued guidelines for pleural disease in 2010. Regarding intrapleural fibrinolytic therapy, the results of Multicenter Intrapleural Sepsis Trial (MIST)—two were reported in 2011 following MIST-1 in 2005, demonstrating the usefulness of intrapleural fibrinolytic therapy. Subsequently, a RAPID (renal, age, purulence, infection source, and dietary factors) risk category was proposed in 2014 as a prognostic factor for pleural infection using MIST-1 and MIST-2 data. -
Pleurisy Brochure
EFFECTS OF PLEURISY HOW IS PLEURISY TREATED? When dry pleurisy heals, it leaves strands The inflammation of pleurisy is treated of fibrous tissue (adhesions) strung by attacking the infection that may have between the lung and the wall of the caused it. A pleurisy caused by some chest, tying them together. Sometimes lung disease is treated, first of all, by these adhesions are so extensive that identifying the underlying disease and they limit the movement of the lungs. But giving whatever treatment is available for usually the soreness disappears and the it. P LEURISY adhesions stretch so much that they no longer cause any difficulty. To limit the pain of pleurisy, limiting the movements of the lungs may be In wet pleurisy, the fluid builds up in the desirable. The health professional may pleural cavity. There may be enough to suggest lying on the sore side, in a restrict the movement of the lungs and special way - for example, on a firm What you need to know therefore the ability to breathe, On the surface to limit breathing movement on other hand, the increasing fluid may that side wnough to reduce stretching seperate the linings so that the movement of sore tissues. They may also perscribe of the chest wall and the sensitive outer medication for the pain itself. lining is limited - causing no pain to subside. For dry pleurisy, such treatment is generally enough. In wet pleurisy, the A large amount of fluid displaces the health professional may decide to remove heart as well as the lung. The lung may the fluid by drawing it out with a needle.